Article
Epigenetic dysregulation in acute myeloid leukemia.
Seminars in hematology - 1 Jun 2025
Schrezenmeier Jens, Huntly B J P
Abstract excerpt
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy defined by the clonal expansion of undifferentiated myeloid blasts with a block in differentiation and aberrant self-renewal. While recurrent genomic mutations are well-documented in AML, epigenetic dysregulation has emerged as an equally pivotal driver of leukemogenesis, a notion corroborated by the frequent recurrence of mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
